Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Oct;80(2):309–314. doi: 10.1111/j.1476-5381.1983.tb10035.x

The effects of (+)-amphetamine, alpha-methyltyrosine, and alpha-methylphenylalanine on the concentrations of m-tyramine and alpha-methyl-m-tyramine in rat striatum.

D F Dougan, A M Duffield, P H Duffield, D N Wade
PMCID: PMC2045018  PMID: 6652380

Abstract

The concentration in rat striatum of the meta and para isomers of tyramine and alpha-methyltyramine, after the administration of (+)-amphetamine, alpha-methyl-p-tyrosine (AMPT) and alpha-methylphenylalanine (AMPA) has been determined using chemical ionization gas chromatography mass spectrometry (c.i.g.c.m.s.). Twenty hours after the last of 7 daily injections of (+)-amphetamine (5 mg kg-1 i.p.) the concentration of alpha-methyl-p-tyramine in striatal tissue increased twofold compared to the concentration 20 h after a single injection. In contrast the concentration of alpha-methyl-m-tyramine did not change. alpha-Methyl-m-tyramine and alpha-methyldopamine were found in the striatum at concentrations of 42 ng g-1 and 13.5 ng g-1 respectively after treatment of rats 20 h before with AMPA (100 mg kg-1 i.p.). After treatment with AMPT (100 mg kg-1, 20 h before decapitation) only the para isomer of alpha-methyltyramine could be detected (13.7 ng g-1) although the striatal concentration of alpha-methyldopamine was 274 ng g-1, a level 20 times greater than that observed after AMPA treatment. The combined administration of both AMPT and AMPA (100 mg kg-1 each, 20 h) resulted in a reduction of the striatal concentration of alpha-methyl-m-tyramine but not alpha-methyl-p-tyramine. These data suggest that alpha-methyl-m-tyramine in rat striatum is formed by the enzyme tyrosine hydroxylase on substrate AMPA, rather than by ring dehydroxylation of alpha-methyldopa and alpha-methyldopamine. Significant reductions in the striatal concentrations of m-tyramine 2 h after the administration of AMPT, suggest that tyrosine hydroxylase is involved similarly in the production of m-tyramine.

Full text

PDF
309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boulton A. A., Juorio A. V., Philips S. R., Wu P. H. The effects of reserpine and 6-hydroxydopamine on the concentrations of some arylakylamines in rat brain. Br J Pharmacol. 1977 Jan;59(1):209–214. doi: 10.1111/j.1476-5381.1977.tb06996.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Danielson T. J., Boulton A. A. Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate. Eur J Pharmacol. 1976 Jun;37(2):257–264. doi: 10.1016/0014-2999(76)90033-9. [DOI] [PubMed] [Google Scholar]
  3. Danielson T. J., Wishart T. B., Boulton A. A. Effect of acute and chronic injections of amphetamine on intracranial self-stimulation (ICS) and some aryl alkyl amines and the rat brain. Life Sci. 1976 Jun 1;18(11):1237–1243. doi: 10.1016/0024-3205(76)90200-9. [DOI] [PubMed] [Google Scholar]
  4. Duffield P. H., Dougan D. F., Wade D. N., Duffield A. M. A chemical ionization gas chromatographic mass spectrometric assay for octopamine and tyramine in rat brain. Biomed Mass Spectrom. 1981 Apr;8(4):170–173. doi: 10.1002/bms.1200080408. [DOI] [PubMed] [Google Scholar]
  5. Duffield P. H., Dougan D. F., Wade D. N., Duffield A. M. Absence of alpha-methyldopamine in rat striatum after chronic administration of d-amphetamine. Life Sci. 1982 May 17;30(20):1701–1705. doi: 10.1016/0024-3205(82)90302-2. [DOI] [PubMed] [Google Scholar]
  6. Dyck L. E., Boulton A. A., Jones R. S. A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices. Eur J Pharmacol. 1980 Nov 7;68(1):33–40. doi: 10.1016/0014-2999(80)90057-6. [DOI] [PubMed] [Google Scholar]
  7. Freeman J. J., Sulser F. Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action. J Pharmacol Exp Ther. 1972 Nov;183(2):307–315. [PubMed] [Google Scholar]
  8. Ishimitsu S., Fujimoto S., Ohara A. Formation of m-tyrosine and o-tyrosine from L-phenylalanine by rat brain homogenate. Chem Pharm Bull (Tokyo) 1980 May;28(5):1653–1655. doi: 10.1248/cpb.28.1653. [DOI] [PubMed] [Google Scholar]
  9. Juorio A. V., Danielson T. J. Effect of haloperidol and d-amphetamine on cerebral tyramine and octopamine levels. Eur J Pharmacol. 1978 Jul 1;50(1):79–82. doi: 10.1016/0014-2999(78)90256-x. [DOI] [PubMed] [Google Scholar]
  10. Juorio A. V. Drug-induced changes in the formation, storage and metabolism of tyramine in the mouse. Br J Pharmacol. 1979 Jul;66(3):377–384. doi: 10.1111/j.1476-5381.1979.tb10841.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Juorio A. V. Effect of stress and L-DOPA administration on mouse striatal tyramine and homovanillic acid levels. Brain Res. 1979 Dec 21;179(1):186–189. doi: 10.1016/0006-8993(79)90505-5. [DOI] [PubMed] [Google Scholar]
  12. Juorio A. V. Effects of D-amphetamine and antipsychotic drug administration on striatal tyramine levels in the mouse. Brain Res. 1977 Apr 22;126(1):181–184. doi: 10.1016/0006-8993(77)90227-x. [DOI] [PubMed] [Google Scholar]
  13. Juorio A. V. Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat. Br J Pharmacol. 1980 Nov;70(3):475–480. doi: 10.1111/j.1476-5381.1980.tb08726.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kuczenski R. Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism. J Pharmacol Exp Ther. 1980 Oct;215(1):135–142. [PubMed] [Google Scholar]
  15. Kuczenski R. Biphasic effects of amphetamine on striatal dopamine dynamics. Eur J Pharmacol. 1977 Dec 1;46(3):249–257. doi: 10.1016/0014-2999(77)90340-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES